Internal Medicine Alert (Vol. 38, No. 6) - March 30, 2016

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: March 2016

Valid through: March 2019

Target Audience

This CME activity is intended for the internist/family physician.


  • Use of Smartphone Applications for Patients’ Health and Fitness
  • Acupuncture for Acute Low Back Pain in the Emergency Department
  • Eat Less Sugar: The New National Dietary Guidelines
  • Prescient Warning Symptoms: A New Target for Sudden Cardiac Death Prevention
  • Pharmacology Update: Coagulation Factor IX (Recombinant), Albumin Fusion Protein
  • Clinical Briefs: Ambulatory BP for All; What’s the Deal with Grapefruit Juice?; Smoking and Low Back Pain


  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe the advantages, disadvantages and controversies surrounding the latest advances in the diagnosis and treatment of disease
  • Identify cost-effective treatment regimens
  • Explain the advantages and disadvantages of new disease screening procedures.

Credit Available


  • Maximum of 2.0 AMA PRA Category 1 Credits
  • 2.0 AOA Category 2-B credits
  • 1.0 AAFP Credits


This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation


AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

The American Osteopathic Association has approved this continuing education activity for up to 2.0 AOA Category 2-B credits.

Internal Medicine Alert has been reviewed and is acceptable for up to 1.0 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins January 15, 2016. Term of approval is for one year from this date with the option of yearly renewal.

Faculty Listing


Stephen A. Brunton, MD

Adjunct Professor of Pharmacy Practice, College of Pharmacy, Roseman University of Health Sciences, Salt Lake City  



James Chan, PharmD, PhD

Pharmacy Quality and

Outcomes Manager, Kaiser

Permanente, Oakland, CA


William T. Elliott, MD, FACP

Chair, Formulary Committee,

Northern California Kaiser

Permanente; Assistant Clinical

Professor of Medicine, University of California, San Francisco


William C. Haas III, MD, MBA

Integrative Medicine Fellow, Department of Family and Community Medicine,
University of Arizona, Tucson


Harold L. Karpman, MD, FACC, FACP

Clinical Professor of Medicine

UCLA School of Medicine


David Kiefer, MD

Clinical Assistant Professor, Department of Family Medicine,

University of Wisconsin

Clinical Assistant Professor of Medicine, Arizona Center for Integrative Medicine

University of Arizona, Tucson


Louis Kuritzky, MD

Clinical Assistant Professor,

University of Florida, Gainesville


Cara Pellegrini, MD

Assistant Professor of Medicine,


Cardiology Division, Electrophysiology Section,

San Francisco VA Medical Center



Gerald Roberts, MD

Senior Attending Physician Long Island Jewish Medical Center NS/LIJ Health Care System New Hyde Park, NY


Financial Disclosure

Internal Medicine Alert’s editor Stephen Brunton, MD, is a retained consultant for Abbott, Actavis, AstraZeneca, Becton Dickinson, Boehringer Ingelheim, Cempra, Exact Sciences, Janssen, Lilly, Mylan, Novo Nordisk, and Teva; he serves on the speakers bureau of AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Teva. Contributing editor Louis Kuritzky is a retained consultant for AbbVie, Allergan, AstraZeneca, Janssen, Lilly, Lundbeck, Medscape, Novo Nordisk, and Sanofi Aventis; he serves on the speakers bureau of Lilly and Lundbeck. Peer reviewer Gerald Roberts, MD; executive editor Leslie Coplin; and associate managing editor Jonathan Springston report no financial relationships relevant to this field of study.

Drs. Chan, Elliott, Karpman, Haas, and Pellegrini report no financial relationships relevant to this field of study. Dr. Kiefer reports he is a consultant for WebMD.

Copyright 2016, AHC Media. All rights reserved.